Q4 Results 2022: Real estate player DLF Limited and drug company Abbott India announced their March quarter results on Tuesday. Here are keyhighlights of the results.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

DLF Q4 results 2022: profit declines 16% to Rs 405.33 cr

Realty major DLF on Tuesday reported a 16 per cent decline in its consolidated net profit to Rs 405.33 crore for the quarter ended in March.

Its net profit stood at Rs 480.94 crore in the year-ago period, the company said in a regulatory filing.

Total income declined to Rs 1,652.13 crore during the fourth quarter of the last fiscal from Rs 1,906.59 crore in the corresponding period of the previous year.

Net profit rose to Rs 1,500.86 crore during the last financial year from Rs 1,093.61 crore in the 2020-21 fiscal year.

Total income rose to Rs 6,137.85 crore in 2021-22 from Rs 5,944.89 crore in the previous year. 

DLF shares ended at Rs 334.15 on the BSE, up nearly 2.06 per cent.

See Zee Business Live TV Streaming Below:

Abbott India Q4 results 2022: net profit up 39% at Rs 211 cr

Drug firm Abbott India on Tuesday said its net profit increased by 39 per cent to Rs 211 crore for the fourth quarter ended March 2022.

The company had reported a net profit of Rs 152 crore in the January-March quarter of 2020-21 fiscal.

Revenue from operations rose to Rs 1,255 crore in the period under review as compared with Rs 1,096 crore in the year-ago period, it added.

For the year ended March 31, 2022, the company reported a net profit of Rs 799 crore. It stood at Rs 691 crore in FY21.

Revenue from operations rose to Rs 4,919 crore last fiscal, as against Rs 4,310 crore in the previous year.

The company said its board has approved a payment of final dividend of Rs 145 and special dividend of Rs 130 per share of Rs 10 each for the year ended March 2022. 

Abbott India shares ended at Rs 17635.70 on the BSE, up nearly 7 per cent.  

With Inputs from PTI